FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100367 [Registered on: 05/01/2026] Trial Registered Prospectively
Last Modified On: 05/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of an Oil based Scalp Serum in the Management of Khalitya (Excessive Hair Fall) 
Scientific Title of Study   A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Keshkusum An Oil based Scalp Serum As Keshya Therapy In Reducing Khalitya (Excessive Hair Fall) Among Healthy Individuals. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Trisha Surendra Suvarna 
Designation  PG Scholar (Swasthavritta) 
Affiliation  Padmashree Dr DY Patil Deemed To Be University, School Of Ayurveda. 
Address  DY Patil Ayurvedic Hospital, 1st floor, Swasthyarakshan OPD No-6 and Kayachikitsa OPD No-1, Sector 7, Nerul east, Navi Mumbai

Thane
MAHARASHTRA
400706
India 
Phone  8454809009  
Fax    
Email  tri.suv.bams24@dypatil.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pratik Patil 
Designation  Associate Professor 
Affiliation  Padmashree Dr DY Patil Deemed To Be University, School Of Ayurveda. 
Address  Padmashree Dr DY Patil Deemed to be University, School Of Ayurveda, Sector 7, Nerul east, Navi Mumbai

Thane
MAHARASHTRA
400706
India 
Phone  9762224740  
Fax    
Email  pratik.patil@dypatil.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Trisha Surendra Suvarna 
Designation  PG Scholar (Swasthvritta) 
Affiliation  Padmashree Dr DY Patil Deemed To Be University, School Of Ayurveda. 
Address  Padmashree Dr DY Patil Deemed to be University,School of Ayurveda, Sector 7, Nerul east, Navi Mumbai

Thane
MAHARASHTRA
400706
India 
Phone  8454809009  
Fax    
Email  tri.suv.bams24@dypatil.edu  
 
Source of Monetary or Material Support  
Padmashree Dr DY Patil Deemed to be University, School of Ayurveda, Sector 7, Nerul east, Navi Mumbai, Maharashtra- 400706 India 
 
Primary Sponsor  
Name  Dr Trisha Surendra Suvarna 
Address  Padmashree Dr DY Patil Deemed to be University, School Of Ayurveda, 1st floor- Swasthyarakshan OPD No-6 and OPD No-1 (Kayachikitsa) Sector-7, Nerul east, Navi Mumbai, Maharashtra- 400706 India. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Trisha Surendra Suvarna  DY Patil Ayurvedic Hospital   Padmashree Dr DY Patil Deemed to be University, School of Ayurveda, 1st floor, Swasthyarakshan OPD No-6 and Kayachikitsa OPD No-1, Sector 7, Nerul east, Navi Mumbai, Maharashtra- 400706 India.
Thane
MAHARASHTRA 
8454809009

tri.suv.bams24@dypatil.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DY Patil Deemed to be University, School of Ayurveda.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L00-L99||Diseases of the skin and subcutaneous tissue. Ayurveda Condition: KHALITYAM/KHALATI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Keshkusum, Reference: Bhavaprakash, Route: Topical, Dosage Form: Taila, Dose: 1(NA), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: No, Additional Information: Keshkusum- An Oil based Scalp Serum is advised in sufficient quantity
2Comparator ArmDrugClassical(1) Medicine Name: Bhringraj Ghanavati, Reference: Ayurvedic Pharmacopoeia of India , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: No, Additional Information: Nil
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1.Individuals aged 18 to 45 years.
2.Both males and females with self-reported excessive hair fall (with the females having 40-50 counts of hair fall and male having 25-30 counts of hair fall) as determined from 60 second hair combing method at screening visit.
3.Good general health with no diagnosed systemic or dermatological illness.
4.Willingness to provide informed written consent and comply with study protocol. 
 
ExclusionCriteria 
Details  1.Pregnant women and Lactating mothers.
2.Any systemic illness (e.g., thyroid dysfunction, anemia , PCOS) and treatments (e.g.chemotherapy) that could cause secondary hair fall.
3.Use of topical or oral hair loss treatments in the last 3 months.
4.Individuals with diagnosed alopecia areata, androgenic alopecia, or scalp infections. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To reduce hair fall, dandruff, roughness of hair surface, itching of hair scalp, dryness of hair   15th day,30th day, 45th day, 60th day 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   09/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title

A Randomized Comparative Clinical Study To Evaluate The Efficacy Of  Keshkusum” -An Oil based Scalp Serum As Keshya Therapy in Reducing Khalitya (Excessive Hair Fall) Among Healthy Individuals.

 

PG Scholar

Dr. Trisha S. Suvarna

Guide

Dr. Pratik Patil

Study site

Padmashree Dr D Y Patil Deemed to be University, School of Ayurveda, 

Nerul, Navi Mumbai-400706.

Study Design

Randomised, open labelled, double arm , comparative prospective clinical study.

Study duration

60 days 

Aim

To evaluate the clinical efficacy of  Keshkusum” -An Oil based Scalp Serum as a topical Keshya therapy in reducing  Khalitya (Excessive Hair fall) among healthy individuals .

 

 Objectives

  1. To develop and standardize  Keshkusum” -An Oil based Scalp Serum
  2. To evaluate the changes in reduction of hair fall.
  3. To provide clinical evidences on how classical Ayurvedic herbs and practices can be reformulated into  modern, user-friendly formats like serums.
  4. To assess patient satisfaction and compliance of the oil-based serum.

 

 

Population to be studied

Healthy individuals with hair fall will be screened from Swasthya rakshan OPD No-6, Kayachikitsa OPD No-1 and Screening Camps conducted by Padmashree D.Y Patil University School of Ayurveda, Nerul, Navi Mumbai.    

Sample size

GROUP A -35 participants (considering 20% dropout rate)

GROUP B -35 participants (considering 20% dropout rate)

 

Inclusion criteria 

 

 

 

 

 

1.     Individuals aged 18 to 45 years .

2.     Both males and females with self-reported excessive hair fall (with the females having  40-50 counts of hair fall and male having 25-30 counts of hair fall) as determined from 60 second hair combing method at screening visit.

3.     Good general health with no diagnosed systemic or dermatological illness.

4.     Willingness to provide informed written consent and comply with study protocol. 

 

 

Exclusion criteria 

        1.Pregnant women and Lactating mothers.

        2.Any systemic illness (e.g., thyroid dysfunction, anemia , PCOS) and treatments (e.g. chemotherapy) that could cause secondary hair fall. 

         3. Use of topical or oral hair loss treatments in the last 3 months 

         4.Individuals with diagnosed alopecia areata, androgenic alopecia, or scalp infections

Efficacy parameters

1.     Khalitya signs and symptoms by  VAS Scale

2.     Hair Pull test.

3.     60 second Hair comb test

4.     Dermatoscope

5.     HairDex Quality of Life Questionnaire

Safety parameters

Adverse events recording.

Efficacy & Safety parameters Assessment Schedule

1.     Khalitya signs and symptoms by  VAS Scale- V1,V2,V3,V4.V5

2.     Hair Pull test- V1,V2,V3,V4,V5

3.     60 second Hair comb test- V1,V2,V3,V4,V5

4.     Dermatoscope- V1,V5

5.     Physical examination: will be done on V1, V2, V3, V4, V5

6.     HairDex Quality of Life Questionnaire V1 and V5

7.     Questionnaire after completion of treatment-V5

Statistical Analysis

Inter-Group Comparison: 

Mann-Whitney U test (for non-parametric data), Unpaired t test (parametric data)

 

S.NO.

GROUPS

GROUP A

GROUP B

1.

PROCEDURE

Keshkusum -An Oil Based Scalp Serum + Bhringaraj Ghanavati

Bhringraj  Ghanavati

2.

ROUTE

Oral +Topical

Oral

3.

DOSAGE

Keshkusum  - Q.S

Bhringraj Ghanavati -1 tablet (250 mg) thrice daily

Bhringraj Ghanavati -1 tablet (250 mg) thrice daily

4.

TIME OF ADMINISTRATION

Keshkusum  – once at night in sufficient quantity.

Bhringraj  Ghanavati -Morning, Afternoon and Night after food.

Bhringraj  Ghanavati – Morning, Afternoon and Night after food.

5.

DURATION

60 days

60 days

6.

NO. OF PARTICIPANTS

30

30

7.

VISITS/ FOLLOW UP

15th day ,

30th day,  

45th day, 

60th day

15th day ,

30th day,  

45th day, 

60th day

 

 
Close